Berlin, January 27, 2023 -The Chairman of the Supervisory Board of Epigenomics AG, Heino von Prondzynski, informed the Boards today that he will resign from his mandate effective March 31, 2023, for health reasons and will leave the Supervisory Board at that time. Mr. von Prondzynski has been Chairman of the Supervisory Board of Epigenomics […]
Category: Insider Information
27. January 2023
Epigenomics AG: Resignation of the Chairman of the Supervisory Board Heino von Prondzynski
Read more
27. January 2023
Epigenomics AG: Resignation of the Chairman of the Supervisory Board Heino von Prondzynski
Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Resignation of the Chairman of the Supervisory Board Heino von Prondzynski 27-Jan-2023 / 14:16 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content […]
21. December 2022
Epigenomics AG: Further raise of earnings guidance for the current fiscal year 2022
Epigenomics AG / Key word(s): Change in ForecastEpigenomics AG: Further raise of earnings guidance for the current fiscal year 2022 21-Dec-2022 / 11:18 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for […]
14. December 2022
Epigenomics Releases Performance Data on Next Generation Test
Epigenomics AG / Key word(s): Study results/MiscellaneousEpigenomics Releases Performance Data on Next Generation Test 14-Dec-2022 / 05:11 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Epigenomics […]
19. September 2022
Epigenomics AG: Raise of earnings guidance for the current fiscal year 2022 due to currency gains and lower study costs
Epigenomics AG / Key word(s): Change in Forecast/ForecastEpigenomics AG: Raise of earnings guidance for the current fiscal year 2022 due to currency gains and lower study costs 19-Sep-2022 / 10:36 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS – a service of EQS Group […]
09. September 2022
Epigenomics AG: Capital reduction planned at a ratio of 4 : 1
Epigenomics AG / Key word(s): Corporate Action/AGM/EGM Epigenomics AG: Capital reduction planned at a ratio of 4 : 1 09-Sep-2022 / 19:19 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content […]